HANGZHOU TIGERMED CONSULTING CO., LTD Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd
Equities
300347
CNE100001KV8
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.11 CNY | -0.94% |
|
+18.86% | +7.53% |
| Apr. 25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
| Apr. 25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
ETFs positioned on Hangzhou Tigermed Consulting Co., Ltd
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.98% | 1 M€ | -9.86% | - | |
| 0.69% | 2 M€ | -12.95% | - | |
| 0.18% | 35 M€ | -5.85% | - | |
| 0.02% | 2 M€ | -.--% | ||
| 0.02% | 7 M€ | -.--% | - | |
| 0.02% | 4 M€ | -11.56% | ||
| 0.01% | 117 M€ | +1.00% | - | |
| 0.00% | 2,808 M€ | +7.44% | - | |
| 0.00% | 149 M€ | +3.96% | - | |
| 0.00% | 441 M€ | +6.14% | - | |
| 0.00% | 31 M€ | +4.25% | - | |
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 34 M€ | +6.29% | - | |
| 0.00% | 34 M€ | +2.04% | - | |
| 0.00% | 39 M€ | +3.82% | - | |
| 0.00% | 302 M€ | +4.05% | - | |
| 0.00% | 17 M€ | +1.40% | - |
Hangzhou Tigermed Consulting Co, Ltd. specialises in providing professional services to pharmaceutical and biotech companies. The group supports its clients in all processes of clinical development and product commercialization. Net sales break down by activity as follows:
- provision of clinical trial services and related technological services (51.8%);
- provision of clinical research consulting services (48.2%).
China accounts for 46% of sales.
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
59.11
CNY
Average target price
73.04
CNY
Spread / Average Target
+23.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.53% | 6.6B | |
| +26.28% | 42.68B | |
| -3.99% | 42.4B | |
| +45.32% | 40.04B | |
| -6.20% | 28.31B | |
| +6.36% | 24.94B | |
| -21.47% | 18.96B | |
| +27.58% | 12.3B | |
| -2.75% | 11.95B | |
| -2.02% | 11.55B |
- Stock Market
- Equities
- 300347 Stock
- Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd
